|
|
OTC Healthcare in Latin America to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 124 seiten | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market covering eight countries in Latin America. This report is a comprehensive resource for market, category and s.....
Introduction This databook provides key data and information on the OTC healthcare market covering eight countries in Latin America. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market, category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in Latin America increased at a compound annual growth rate of 8.1% between 2003 and 2008. The analgesics category led the OTC healthcare market in Latin America, accounting for a share of 20%. The leading players in the Latin American OTC healthcare market include Johnson & Johnson,GlaxoSmithKline Plc and Bayer AG. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Latin America *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 OVERVIEW 28 Value Analysis 28 Chapter 4 Latin America OTC Healthcare - Market Overview 29 Value analysis (US dollar), 2003?08 29 Value analysis (US dollar), 2008?13 31 Company share analysis 34 Distribution analysis 37 Chapter 5 Leading Company Profiles 39 Johnson & Johnson 39 GlaxoSmithKline Plc 41 Chapter 6 Category Analysis: Analgesics 44 Value analysis (US dollar), 2003?08 44 Value analysis (US dollar), 2008?13 45 Company share analysis 47 Distribution analysis 50 Chapter 7 Category Analysis: Topical OTC Medicines 52 Value analysis (US dollar), 2003?08 52 Value analysis (US dollar), 2008?13 53 Company share analysis 55 Distribution analysis 58 Chapter 8 Category Analysis: Cough and Cold Preparations 60 Value analysis (US dollar), 2003?08 60 Value analysis (US dollar), 2008?13 61 Company share analysis 63 Distribution analysis 66 Chapter 9 Category Analysis: Indigestion Preparations 68 Value analysis (US dollar), 2003?08 68 Value analysis (US dollar), 2008?13 69 Company share analysis 71 Distribution analysis 74 Chapter 10 Category Analysis: Medicated Skin Products 76 Value analysis (US dollar), 2003?08 76 Value analysis (US dollar), 2008?13 77 Company share analysis 79 Distribution analysis 82 Chapter 11 Category Analysis: First Aid Kits 84 Value analysis (US dollar), 2003?08 84 Value analysis (US dollar), 2008?13 85 Company share analysis 86 Distribution analysis 88 Chapter 12 Category Analysis: Other OTC Healthcare Products 90 Value analysis (US dollar), 2003?08 90 Value analysis (US dollar), 2008?13 91 Company share analysis 93 Distribution analysis 96 Chapter 13 Category Analysis: Plasters & Bandages 98 Value analysis (US dollar), 2003?08 98 Value analysis (US dollar), 2008?13 99 Company share analysis 101 Distribution analysis 103 Chapter 14 Category Analysis: Traditional Medicines 105 Value analysis (US dollar), 2003?08 105 Value analysis (US dollar), 2008?13 106 Company share analysis 107 Distribution analysis 109 Chapter 15 Category Analysis: Vitamins and Minerals 111 Value analysis (US dollar), 2003?08 111 Value analysis (US dollar), 2008?13 112 Company share analysis 114 Distribution analysis 117 Chapter 16 Research Methodology 119 Methodology overview 119 Secondary research 120 Market modeling 121 Creating an initial data model 121 Revising the initial data model 121 Creating a final estimate 122 Creating demographic value splits 122 Primary research 122 Data finalization 123 Ongoing research 123 Chapter 17 APPENDIX 124 Future readings 124 How to contact experts in your industry 124 Disclaimer 124 LIST OF FIGURES Figure 1: Latin America OTC healthcare value and value forecast, 2003?13 ($m, nominal prices) 32 Figure 2: Latin America OTC healthcare category growth comparison, by value, 2003?13 33 Figure 3: Latin America OTC healthcare company share (top five companies), by value, 2007?08 (%) 36 Figure 4: Latin America OTC healthcare distribution channels, by value, 2007?08 (%) 38 Figure 5: Latin America analgesics value and value forecast, 2003?13 ($m, nominal prices) 46 Figure 6: Latin America analgesics category growth comparison, by value, 2003?13 46 Figure 7: Latin America analgesics company share (top five companies), by value, 2007?08 (%) 49 Figure 8: Latin America analgesics distribution channels, by value, 2007?08 (%) 51 Figure 9: Latin America topical OTC medicines value and value forecast, 2003?13 ($m, nominal prices) 54 Figure 10: Latin America topical OTC medicines category growth comparison, by value, 2003?13 54 Figure 11: Latin America topical OTC medicines company share, by value, 2007?08 (%) 57 Figure 12: Latin America topical OTC medicines distribution channels, by value, 2007?08 (%) 59 Figure 13: Latin America cough and cold preparations value and value forecast, 2003?13 ($m, nominal prices) 62 Figure 14: Latin America cough and cold preparations category growth comparison, by value, 2003?13 62 Figure 15: Latin America cough and cold preparations company share (top five companies), by value, 2007?08 (%) 65 Figure 16: Latin America cough and cold preparations distribution channels, by value, 2007?08 (%) 67 Figure 17: Latin America indigestion preparations value and value forecast, 2003?13 ($m, nominal prices) 70 Figure 18: Latin America indigestion preparations category growth comparison, by value, 2003?13 70 Figure 19: Latin America indigestion preparations company share (top five companies), by value, 2007?08 (%) 73 Figure 20: Latin America indigestion preparations distribution channels, by value, 2007?08 (%) 75 Figure 21: Latin America medicated skin products value and value forecast, 2003?13 ($m, nominal prices) 78 Figure 22: Latin America medicated skin products category growth comparison, by value, 2003?13 78 Figure 23: Latin America medicated skin products company share (top five companies), by value, 2007?08 (%) 81 Figure 24: Latin America medicated skin products distribution channels, by value, 2007?08 (%) 83 Figure 25: Latin America first aid kits value and value forecast, 2003?13 ($m, nominal prices) 85 Figure 26: Latin America first aid kits company share, by value, 2007?08 (%) 87 Figure 27: Latin America first aid kits distribution channels, by value, 2007?08 (%) 89 Figure 28: Latin America other OTC healthcare products value and value forecast, 2003?13 ($m, nominal prices) 92 Figure 29: Latin America other OTC healthcare products category growth comparison, by value, 2003?13 92 Figure 30: Latin America other OTC healthcare products company share (top five companies), by value, 2007?08 (%) 95 Figure 31: Latin America other OTC healthcare products distribution channels, by value, 2007?08 (%) 97 Figure 32: Latin America plasters & bandages value and value forecast, 2003?13 ($m, nominal prices) 100 Figure 33: Latin America plasters & bandages category growth comparison, by value, 2003?13 100 Figure 34: Latin America plasters & bandages company share, by value, 2007?08 (%) 102 Figure 35: Latin America plasters & bandages distribution channels, by value, 2007?08 (%) 104 Figure 36: Latin America traditional medicines value and value forecast, 2003?13 ($m, nominal prices) 106 Figure 37: Latin America traditional medicines company share, by value, 2007?08 (%) 108 Figure 38: Latin America traditional medicines distribution channels, by value, 2007?08 (%) 110 Figure 39: Latin America vitamins and minerals value and value forecast, 2003?13 ($m, nominal prices) 113 Figure 40: Latin America vitamins and minerals category growth comparison, by value, 2003?13 113 Figure 41: Latin America vitamins and minerals company share (top five companies), by value, 2007?08 (%) 116 Figure 42: Latin America vitamins and minerals distribution channels, by value, 2007?08 (%) 118 Figure 43: Annual data review process 120 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: Latin America OTC healthcare value (country-wise), 2003?08 ($m, nominal prices) 28 Table 4: Latin America OTC healthcare value (country-wise) forecast, 2008?13 ($m, nominal prices) 28 Table 5: Latin America OTC healthcare value, 2003?08 ($m, nominal prices) 30 Table 6: Latin America OTC healthcare value forecast, 2008?13 ($m, nominal prices) 31 Table 7: Latin America OTC healthcare company share (top 20 companies) by value, 2007?08 (%) 34 Table 8: Latin America OTC healthcare value, by company, 2007?08 ($m, nominal prices) 35 Table 9: Latin America OTC healthcare distribution channels, by value, 2007?08 (%) 37 Table 10: Latin America OTC healthcare value, by distribution channel, 2007?08 ($m, nominal prices) 37 Table 11: Johnson & Johnson key facts 39 Table 12: GlaxoSmithKline Plc key facts 41 Table 13: Latin America analgesics value, 2003?08 ($m, nominal prices) 44 Table 14: Latin America analgesics value forecast, 2008?13 ($m, nominal prices) 45 Table 15: Latin America analgesics company share (top 20 companies) by value, 2007?08 (%) 47 Table 16: Latin America analgesics value, by company, 2007?08 ($m, nominal prices) 48 Table 17: Latin America analgesics distribution channels, by value, 2007?08 (%) 50 Table 18: Latin America analgesics value, by distribution channel, 2007?08 ($m, nominal prices) 50 Table 19: Latin America topical OTC medicines value, 2003?08 ($m, nominal prices) 52 Table 20: Latin America topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 53 Table 21: Latin America topical OTC medicines company share by value, 2007?08 (%) 55 Table 22: Latin America topical OTC medicines value, by company, 2007?08 ($m, nominal prices) 56 Table 23: Latin America topical OTC medicines distribution channels, by value, 2007?08 (%) 58 Table 24: Latin America topical OTC medicines value, by distribution channel, 2007?08 ($m, nominal prices) 58 Table 25: Latin America cough and cold preparations value, 2003?08 ($m, nominal prices) 60 Table 26: Latin America cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 61 Table 27: Latin America cough and cold preparations company share (top 20 companies) by value, 2007?08 (%) 63 Table 28: Latin America cough and cold preparations value, by company, 2007?08 ($m, nominal prices) 64 Table 29: Latin America cough and cold preparations distribution channels, by value, 2007?08 (%) 66 Table 30: Latin America cough and cold preparations value, by distribution channel, 2007?08 ($m, nominal prices) 66 Table 31: Latin America indigestion preparations value, 2003?08 ($m, nominal prices) 68 Table 32: Latin America indigestion preparations value forecast, 2008?13 ($m, nominal prices) 69 Table 33: Latin America indigestion preparations company share (top 20 companies) by value, 2007?08 (%) 71 Table 34: Latin America indigestion preparations value, by company, 2007?08 ($m, nominal prices) 72 Table 35: Latin America indigestion preparations distribution channels, by value, 2007?08 (%) 74 Table 36: Latin America indigestion preparations value, by distribution channel, 2007?08 ($m, nominal prices) 74 Table 37: Latin America medicated skin products value, 2003?08 ($m, nominal prices) 76 Table 38: Latin America medicated skin products value forecast, 2008?13 ($m, nominal prices) 77 Table 39: Latin America medicated skin products company share (top 20 companies) by value, 2007?08 (%) 79 Table 40: Latin America medicated skin products value, by company, 2007?08 ($m, nominal prices) 80 Table 41: Latin America medicated skin products distribution channels, by value, 2007?08 (%) 82 Table 42: Latin America medicated skin products value, by distribution channel, 2007?08 ($m, nominal prices) 82 Table 43: Latin America first aid kits value, 2003?08 ($m, nominal prices) 84 Table 44: Latin America first aid kits value forecast, 2008?13 ($m, nominal prices) 85 Table 45: Latin America first aid kits company share by value, 2007?08 (%) 86 Table 46: Latin America first aid kits value, by company, 2007?08 ($m, nominal prices) 86 Table 47: Latin America first aid kits distribution channels, by value, 2007?08 (%) 88 Table 48: Latin America first aid kits value, by distribution channel, 2007?08 ($m, nominal prices) 88 Table 49: Latin America other OTC healthcare products value, 2003?08 ($m, nominal prices) 90 Table 50: Latin America other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 91 Table 51: Latin America other OTC healthcare products company share (top 20 companies) by value, 2007?08 (%) 93 Table 52: Latin America other OTC healthcare products value, by company, 2007?08 ($m, nominal prices) 94 Table 53: Latin America other OTC healthcare products distribution channels, by value, 2007?08 (%) 96 Table 54: Latin America other OTC healthcare products value, by distribution channel, 2007?08 ($m, nominal prices) 96 Table 55: Latin America plasters & bandages value, 2003?08 ($m, nominal prices) 98 Table 56: Latin America plasters & bandages value forecast, 2008?13 ($m, nominal prices) 99 Table 57: Latin America plasters & bandages company share by value, 2007?08 (%) 101 Table 58: Latin America plasters & bandages value, by company, 2007?08 ($m, nominal prices) 101 Table 59: Latin America plasters & bandages distribution channels, by value, 2007?08 (%) 103 Table 60: Latin America plasters & bandages value, by distribution channel, 2007?08 ($m, nominal prices) 103 Table 61: Latin America traditional medicines value, 2003?08 ($m, nominal prices) 105 Table 62: Latin America traditional medicines value forecast, 2008?13 ($m, nominal prices) 106 Table 63: Latin America traditional medicines company share by value, 2007?08 (%) 107 Table 64: Latin America traditional medicines value, by company, 2007?08 ($m, nominal prices) 107 Table 65: Latin America traditional medicines distribution channels, by value, 2007?08 (%) 109 Table 66: Latin America traditional medicines value, by distribution channel, 2007?08 ($m, nominal prices) 109 Table 67: Latin America vitamins and minerals value, 2003?08 ($m, nominal prices) 111 Table 68: Latin America vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 112 Table 69: Latin America vitamins and minerals company share (top 20 companies) by value, 2007?08 (%) 114 Table 70: Latin America vitamins and minerals value, by company, 2007?08 ($m, nominal prices) 115 Table 71: Latin America vitamins and minerals distribution channels, by value, 2007?08 (%) 117 Table 72: Latin America vitamins and minerals value, by distribution channel, 2007?08 ($m, nominal prices) 117 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


